Colorectal Cancer Screening Market

Colorectal Cancer Screening Market Size, Share, Growth Analysis, By Type(Stool-based, Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), Stool-DNA Test), By End-user(Hospitals & Clinics, Clinical Laboratories, Diagnostic Imaging Centers, Others), By Region(North America, Europe, Asia-Pacific, Latin America) - Industry Forecast 2024-2031


Report ID: UCMIG35A2910 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Colorectal Cancer Screening Market Insights

Market Overview:

The size of the global market for screening colorectal cancer was $16.29 billion in 2022, and it is expected to increase to $23.03 billion by 2030, with an estimated compound annual growth rate (CAGR) of 4.4% during the forecast period. Colorectal cancer, also known as CRC, initiates with the abnormal growth and spread of cancerous cells in the colon or rectum, which are parts of the digestive tract. Commonly referred to as bowel cancer, this disease typically begins with the formation of non-cancerous polyps in the early stages and may remain asymptomatic, but screening tests can help in its detection.

Colorectal Cancer Screening Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Equipment by segment aggregation, the contribution of the Health Care Equipment in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Colorectal Cancer Screening was estimated to be valued at US$ XX Mn in 2021.

The Colorectal Cancer Screening Market is estimated to grow at a CAGR of XX% by 2028.

The Colorectal Cancer Screening Market is segmented on the basis of Type, End-user, Region.

Based on region, the Colorectal Cancer Screening Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Colorectal Cancer Screening Market are , NOVIGENIX SA , EIKEN CHEMICAL CO., LTD. , Clinical Genomics Technologies Pty Ltd. , Exact Sciences Corporation , Epigenomics AG , bioMérieux, Inc. , Olympus Corporation , KARL STORZ SE & Co. KG , FUJIFILM Holdings America Corporation .

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Colorectal Cancer Screening Market

Report ID: UCMIG35A2910

$5,300
BUY NOW GET FREE SAMPLE